iCAD

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch iCAD and buy or sell other stocks, ETFs, and their options commission-free!

About ICAD

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. 

CEO
Dana R. Brown
CEODana R. Brown
Employees
66
Employees66
Headquarters
Nashua, New Hampshire
HeadquartersNashua, New Hampshire
Founded
1984
Founded1984
Employees
66
Employees66

ICAD Key Statistics

Market cap
105.19M
Market cap105.19M
Price-Earnings ratio
-19.56
Price-Earnings ratio-19.56
Dividend yield
Dividend yield
Average volume
56.42K
Average volume56.42K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.02
52 Week high$4.02
52 Week low
$1.19
52 Week low$1.19

Stock Snapshot

iCAD(ICAD) stock is priced at $3.87, giving the company a market capitalization of 105.19M. It carries a P/E multiple of -19.56.

iCAD(ICAD) stock opened on 2026-02-16 at —. The price climbed to — and dipped to —.

The iCAD(ICAD)'s current trading volume is 0, compared to an average daily volume of 56.42K.

In the last year, iCAD(ICAD) shares hit a 52-week high of $4.02 and a 52-week low of $1.19.

In the last year, iCAD(ICAD) shares hit a 52-week high of $4.02 and a 52-week low of $1.19.

People also own

Based on the portfolios of people who own ICAD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.